Victory Capital Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.9M | Sell |
50,847
-104
| -0.2% | -$48K | 0.02% | 805 |
|
|
2026
Q1 | $24.5M | Buy |
50,951
+1,093
| +2% | +$560K | 0.02% | 795 |
|
|
2025
Q4 | $28M | Buy |
49,858
+19,319
| +63% | +$11M | 0.02% | 757 |
|
|
2025
Q3 | $15.7M | Buy |
30,539
+7,565
| +33% | +$3.3M | 0.01% | 956 |
|
|
2025
Q2 | $7.21M | Sell |
22,974
-1,005
| -4% | -$302K | ﹤0.01% | 1202 |
|
|
2025
Q1 | $7.31M | Buy |
23,979
+7,051
| +42% | +$2.37M | 0.01% | 1163 |
|
|
2024
Q4 | $5.62M | Sell |
16,928
-21,732
| -56% | -$7.37M | 0.01% | 1243 |
|
|
2024
Q3 | $12.9M | Sell |
38,660
-29,826
| -44% | -$11.3M | 0.01% | 1010 |
|
|
2024
Q2 | $28.2M | Buy |
68,486
+10,320
| +18% | +$4.09M | 0.03% | 677 |
|
|
2024
Q1 | $23.5M | Sell |
58,166
-10,491
| -15% | -$3.69M | 0.02% | 750 |
|
|
2023
Q4 | $21M | Buy |
68,657
+12,127
| +21% | +$3.27M | 0.02% | 757 |
|
|
2023
Q3 | $13.7M | Sell |
56,530
-4,526
| -7% | -$1.16M | 0.02% | 895 |
|
|
2023
Q2 | $14.7M | Sell |
61,056
-278
| -0.5% | -$57.7K | 0.02% | 896 |
|
|
2023
Q1 | $11.5M | Sell |
61,334
-15,197
| -20% | -$3.14M | 0.01% | 980 |
|
|
2022
Q4 | $16.3M | Sell |
76,531
-7,440
| -9% | -$1.49M | 0.02% | 850 |
|
|
2022
Q3 | $13.2M | Buy |
83,971
+35,862
| +75% | +$5.72M | 0.02% | 970 |
|
|
2022
Q2 | $7.2M | Buy |
48,109
+639
| +1% | +$92.5K | 0.01% | 1164 |
|
|
2022
Q1 | $7.31M | Buy |
47,470
+1,670
| +4% | +$275K | 0.01% | 1209 |
|
|
2021
Q4 | $9.97M | Sell |
45,800
-11,196
| -20% | -$2.34M | 0.01% | 1129 |
|
|
2021
Q3 | $10.8M | Sell |
56,996
-390
| -0.7% | -$71.1K | 0.01% | 1084 |
|
|
2021
Q2 | $10.1M | Sell |
57,386
-12,250
| -18% | -$2.11M | 0.01% | 1123 |
|
|
2021
Q1 | $11.4M | Buy |
69,636
+28,976
| +71% | +$4.43M | 0.01% | 1108 |
|
|
2020
Q4 | $5.66M | Buy |
40,660
+355
| +0.9% | +$44.7K | 0.01% | 1211 |
|
|
2020
Q3 | $4.5M | Sell |
40,305
-687
| -2% | -$79.4K | 0.01% | 1220 |
|
|
2020
Q2 | $3.81M | Buy |
40,992
+11,477
| +39% | +$977K | 0.01% | 1238 |
|
|
2020
Q1 | $2.17M | Buy |
29,515
+14,859
| +101% | +$1.29M | ﹤0.01% | 1307 |
|
|
2019
Q4 | $1.23M | Buy |
14,656
+2,850
| +24% | +$221K | ﹤0.01% | 1677 |
|
|
2019
Q3 | $992K | Buy |
11,806
+10,508
| +810% | +$794K | ﹤0.01% | 1704 |
|
|
2019
Q2 | $85K | Sell |
1,298
-2,255
| -63% | -$130K | ﹤0.01% | 1661 |
|
|
2019
Q1 | $210K | Sell |
3,553
-947
| -21% | -$56.6K | ﹤0.01% | 1554 |
|
|
2018
Q4 | $238K | Buy |
4,500
+173
| +4% | +$9.5K | ﹤0.01% | 1527 |
|
|
2018
Q3 | $259K | Sell |
4,327
-2,764
| -39% | -$151K | ﹤0.01% | 1552 |
|
|
2018
Q2 | $305K | Buy |
7,091
+974
| +16% | +$39.3K | ﹤0.01% | 1526 |
|
|
2018
Q1 | $214K | Buy |
+6,117
| New | +$223K | ﹤0.01% | 1585 |
|
Other funds holding MEDP
WA
Victory Capital Management's MEDP Position: Q2 2026 in Review
Victory Capital Management reduced its Medpace (MEDP) stake by 0.2% in Q2 2026, selling an estimated $48K and leaving 50,847 shares worth $26.9M. The position accounts for 0.02% of the portfolio, ranked #805.
Victory Capital Management first reported a position in MEDP in Q1 2018 and has held it in 34 quarters since. The position peaked at $28.2M in Q2 2024. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Victory Capital Management held 50,847 shares of Medpace worth $26.9M as of Q2 2026.
- Victory Capital Management sold 104 Medpace shares in Q2 2026, an estimated $48K.
- Medpace made up 0.02% of Victory Capital Management's portfolio in Q2 2026, its #805 holding.
- Victory Capital Management first reported a position in Medpace in Q1 2018 and has held it in 34 quarters since.
- Victory Capital Management's Medpace position peaked at $28.2M in Q2 2024.
- 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.